4th Symposium on Current Strategies in the Treatment of Multiple Myeloma, Lymphoma and Leukemia
This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.
For more information visit: www.cancernetus.net
Onyx Pharmaceuticals, Inc., a subsidiary of Amgen, Inc.
Millennium Pharmaceuticals, Inc.
Novartis Pharmaceuticals, Inc.
Seattle Genetics, Inc.
Scroll to the Bottom of this Information to Begin this Course
Release date: May 25, 2015
Valid through: May 25, 2016
Estimated Time to Complete Activity: 1.0 hours (66 minutes)
This symposium is directed primarily to hematologists/oncologists, radiation oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in hematological malignancies. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.
Statement of Need / Program Overview
This symposium is intended to improve care of patients with hematological malignancies by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of hematological malignancies, this symposium will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Upon completion of this activity, participants should be better able to:
- Identify the role of maintenance therapy for patients with multiple myeloma
- Describe emerging novel therapeutic pathways for multiple myeloma
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
Michael Wang, MD, Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Elisabet E. Manasanch, MD, Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet. The A. Webb Roberts Center for CME of Baylor Health Care System is accredited by the ACCME to provide continuing medical education for physicians.
The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Speaker’s Bureau: Janssen
- No relevant financial relationship
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- No relevant financial relationships
- No relevant financial relationships
All other individuals in a position to control content have no relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this webcast. During the period May 25, 2015 through May 25, 2016, participants must read all of the material and study the educational webcast.
Instructions For Course Participation
This webcast includes text, graphics, and may include multimedia features. There are no fees for participating in or receiving credit for this webcast.
Click on all of the "medical education webcast" links and review the content presented. You must view all of the content to proceed to the post-test.
Read, complete, and submit answers to the post-test questions and evaluation questions online. You must answer all missed questions until you get them correct.
Participants must receive a test score of 100% in order to proceed to the course evaluation, and they must respond to all evaluation questions to receive a letter of credit.If needed, you may save your answers and return to complete your course at a later date. You can find your saved course by selecting "My Courses" or through the main course catalog.
Letter Of Credit & Transcripts
After submitting the webcast evaluation you will have immediate access to view and download your letter of credit as a PDF. You may print the letter of credit, but you may not alter the letter of credit. You can access all your credit letters from the "My Courses" page
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
A. Webb Roberts Center for CME of Baylor Health Care System observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support. To contact CME Provider, call 214-820-2317.